OPTIMARK (Liebel-Flarsheim Company LLC)
Welcome to the PulseAid listing for the OPTIMARK drug offered from Liebel-Flarsheim Company LLC. This Gadolinium-based Contrast Agent [EPC],Magnetic Resonance Contrast Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Liebel-Flarsheim Company LLC |
| NON-PROPRIETARY NAME: | GADOVERSETAMIDE |
| SUBSTANCE NAME: | GADOVERSETAMIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Gadolinium-based Contrast Agent [EPC],Magnetic Resonance Contrast Activity [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2010-12-10 |
| END MARKETING DATE: | 0000-00-00 |
OPTIMARK HUMAN PRESCRIPTION DRUG Details:
| Item Description | OPTIMARK from Liebel-Flarsheim Company LLC |
| LABELER NAME: | Liebel-Flarsheim Company LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 0.5(mmol/mL) |
| START MARKETING DATE: | 2010-12-10 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0019-1177_35c3b4f7-803a-4827-9b0e-4bfeed2b57bf |
| PRODUCT NDC: | 0019-1177 |
| APPLICATION NUMBER: | NDA020975 |
Other GADOVERSETAMIDE Pharmaceutical Manufacturers / Labelers:
